Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Aceragen
Aceragen
(ACGN)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Tilsotolimod
hepatitis c
,
hepatitis
,
hepatitis a
,
carcinoma
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
neoplasms
,
melanoma
Fusidic acid
fibrosis
,
cystic fibrosis
,
pulmonary fibrosis
Sodium chloride
hepatitis c
,
hepatitis
,
hepatitis a
,
psoriasis
,
dermatomyositis
,
melanoma
BAZLITORAN
waldenstrom macroglobulinemia
,
dermatomyositis
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
psoriasis
Bevifimod
fibrosis
,
cystic fibrosis
,
pulmonary fibrosis
Budigalimab
carcinoma
,
neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
REVDOFILIMAB
carcinoma
,
neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
Mk3475
melanoma
Folinoral
hepatitis c
,
hepatitis
,
hepatitis a
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
psoriasis
Arm1
carcinoma
,
neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
Arm2
carcinoma
,
neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use